Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer ; volume:22 ; number:1 ; day:9 ; month:7 ; year:2024 ; pages:1-15 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (9.7.2024), 1-15, 12.2024
- Urheber
-
Lund-Andersen, Christin
Torgunrud, Annette
Kanduri, Chakravarthi
Dagenborg, Vegar J.
Frøysnes, Ida S.
Larsen, Mette M.
Davidson, Ben
Larsen, Stein G.
Flatmark, Kjersti
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05467-2
- URN
-
urn:nbn:de:101:1-2409262140306.716565660876
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lund-Andersen, Christin
- Torgunrud, Annette
- Kanduri, Chakravarthi
- Dagenborg, Vegar J.
- Frøysnes, Ida S.
- Larsen, Mette M.
- Davidson, Ben
- Larsen, Stein G.
- Flatmark, Kjersti
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Rare metastasis in a patient with BRAF-mutated rectal cancer: choroidal metastasis - case report and literature review
Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
Mind your head: two cases of mucosal metastasis of BRAF-mutated melanoma of the scalp
BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis
Disruption of mutated BRAF signaling modulates thyroid cancer phenotype
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
Abdominal tuberculosis mimicking peritoneal metastasis
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Rare metastasis in a patient with BRAF-mutated rectal cancer: choroidal metastasis - case report and literature review
Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
Mind your head: two cases of mucosal metastasis of BRAF-mutated melanoma of the scalp
BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis
Disruption of mutated BRAF signaling modulates thyroid cancer phenotype
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
Abdominal tuberculosis mimicking peritoneal metastasis
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Rare metastasis in a patient with BRAF-mutated rectal cancer: choroidal metastasis - case report and literature review
Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
Mind your head: two cases of mucosal metastasis of BRAF-mutated melanoma of the scalp
BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis
Disruption of mutated BRAF signaling modulates thyroid cancer phenotype
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells